The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease

BJU International

Volumn 105, Issue 4, 2010, Pages 472-475

  Porten, Sima P ^a   Cooperberg, Matthew R ^a   Carroll, Peter R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Localized; Prognosis; Prostate cancer; Radical prostatectomy; Volume

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR BURDEN;

EID: 76149110806     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08774.x     Document Type: Article

References (19)

1. Nicholson B, Theodorescu D. Angiogenesis and prostate cancer tumor growth. J Cell Biochem 2004 91 : 125 50
2. Stamey TA, McNeal JE, Yemoto CM et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999 281 : 1395 1400
3. Stamey TA, Freiha FS, McNeal JE et al. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993 71 : 933 938
4. Epstein JI, Carmichael M, Partin AW et al. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years follow up. J Urol 1993 149 : 1478 1481
5. Soh S, Kattan MW, Berkman S et al. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol 1997 157 : 2212 2218
6. Cooperberg MR, Lubock DP, Mehta SS, Carroll PR. Time trend in clinical risk stratification of prostate cancer: Implications for outcomes (data from CaPSURE). J Urol 2003 170 : S21 S27
7. Renshaw AA, Chang H, D'Amico AV. Estimation of tumor volume in radial prostatectomy specimens in routine clinical practice. Am J Clin Pathol 1997 107 : 704 708
8. Pound CR, Partin AW, Epstein JI, Walsh PC. Prostate specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am 1997 24 : 395 406
9. D'Amico AV, Whittington R, Malkowicz SB et al. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 1998 160 : 2096 2101
10. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999 17 : 1499 1505
11. Nelson BA, Shappell SB, Change SS et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 2006 97 : 1169 1172
12. Solomon K, Levrel O, Anastasiadis AG et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol 2003 43 : 39 44
13. Kikuchi E, Scardino PT, Wheeler TM et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2004 172 : 508 511
14. Merrill MM, Lane BR, Reuther AM et al. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 2007 70 : 294 298
15. Eichelberger LE, Koch MO, Ebel JN et al. Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Modern Pathol 2005 18 : 886 890
16. Van Oort IM, Witjes JA, Kok DEG et al. Maximum tumor diameter is not an independent prognostic factor in high risk localized prostate cancer. World J Urol 2008 26 : 237 241
17. Kattan MW, Eastham JA, Wheeler TM et al. Counseling men with prostate cancer. A nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003 170 : 1792 1797
18. Noguchi M, Kikuchi H, Ishibashi M et al. Percentage of the positive area of bone metastasis is an independent predictor of disease death in advance prostate cancer. Br J Cancer 2003 88 : 195 201
19. Furuya Y, Akakura K, Akimoto S et al. Pattern of progression and survival in hormonally treated metastatic prostate cancer. Int J Urol 1999 6 : 240 244